Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Uterine Cervical Neoplasms 1Prostatic Neoplasms 1Neoplasms 1Multiple Endocrine Neoplasia Type 1 1Fatigue 1Castration-Resistant Prostate Carcinoma 1Castration Resistant Metastatic Prostate Cancer 1Carcinoma, Squamous Cell 1Cachexia 1

Interventions

Therapeutics 20Exercise 16Yoga 15Modafinil 12Surveys and Questionnaires 11Psychiatric Rehabilitation 10Methylphenidate 7Acupuncture Therapy 7Therapeutic Touch 6Ultraviolet Therapy 5Educational Status 5Acceptance and Commitment Therapy 5Walking 4Sugars 4Physical Therapy Modalities 4Palliative Care 4Early Intervention, Educational 4Control Groups 4Behavior Therapy 4methyl hydroxyethyl cellulose 3Touch 3Exercise Therapy 3Epoetin Alfa 3Counseling 3Acupressure 3Standard of Care 2Sodium Chloride 2Resistance Training 2Qigong 2Music Therapy 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Completed × Fatigue × testosterone enanthate × Clear all
NCT00965341 2016-09-13

Testosterone Replacement for Fatigue in Male Hypogonadic Advanced Cancer Patients

M.D. Anderson Cancer Center

Phase 3 Completed
53 enrolled 8 charts

Fatigue, Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡